Crealta Pharmaceuticals Overview
- Founded
-
2013
- Status
-
Acquired/Merged
- Employees
-
31
- Latest Deal Type
-
M&A
- Financing Rounds
-
4
- Investments
-
1
Crealta Pharmaceuticals General Information
Description
Manufacturer of therapeutics products. The company provides KRYSTEXXA and MIGERGOT medicines. It also offers medicine for the treatment of high uric acid and medicine for migraines.
Contact Information
Website
crealtapharma.squarespace.com
Ownership Status
Acquired/Merged
Financing Status
Formerly PE-Backed
Primary Industry
Pharmaceuticals
Other Industries
Other Healthcare
Therapeutic Devices
Acquirer
Primary Office
- 500 West Silver Spring Drive
- Suite K-200
- Glendale, WI 53217
- United States
+1 (847) 000-0000
Crealta Pharmaceuticals Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Crealta Pharmaceuticals Signals
Growth Rate
0.80%
Weekly
Growth
Growth
Weekly Growth
0.80%, 93rd %
-35.5%.
530%
Size Multiple
219x
Median
Size Multiple
219x, 100th %ile
0.00x
0.95x.
413Kx
Key Data Points
Twitter Followers
5.5k
Similarweb Unique Visitors
15.0K
Majestic Referring Domains
314
Crealta Pharmaceuticals Former Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Crealta Pharmaceuticals Investments (1)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| 0000000 00000 | 13-Jan-2014 | 0000000000 | 00000 | Pharmaceuticals |